AlloVir Inc.

NASDAQ: ALVR · Real-Time Price · USD
9.81
0.39 (4.14%)
At close: Mar 18, 2025, 3:59 PM

AlloVir Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 398K 2.56M 1.12M
Gross Profit
n/a -398K -2.56M -1.12M
Operating Income
-65.44M -181.33M -171.2M -169.82M
Interest Income
5.49M 5.73M 1.88M 1.31M
Pretax Income
-58.77M -190.54M -168.97M -170.96M
Net Income
-58.77M -190.42M -168.71M -171.96M
Selling & General & Admin
42.92M 48.26M 52.33M 49.08M
Research & Development
12.34M 132.67M 118.87M 120.73M
Other Expenses
10.19M n/a n/a -1.12M
Operating Expenses
65.44M 180.93M 171.2M 168.7M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 181.33M 171.2M 169.82M
Income Tax Expense
n/a -126K -265K 1.01M
Shares Outstanding (Basic)
4.96M 4.47M 3.3M 2.7M
Shares Outstanding (Diluted)
4.96M 4.47M 3.3M 2.7M
EPS (Basic)
-11.73 -42.09 -50.6 -63.02
EPS (Diluted)
-11.73 -42.09 -50.6 -63.02
EBITDA
-65.44M -190.15M -166.41M -169.84M
EBIT
n/a -190.54M -168.97M -170.96M
Depreciation & Amortization
n/a 398K 2.56M 1.12M